Genomic medicine in the prevention and treatment of atherosclerotic cardiovascular disease

Author： Tuteja Sony   Rader Daniel J  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.9, Iss.4, 2012-06, pp. : 395-404

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PCSK9 in context: A contemporary review of an important biological target for the prevention and treatment of atherosclerotic cardiovascular disease

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 2, 2018-02 ,pp. : 270-282

John Wiley & Sons Inc

Access to resources Recommend Favorite

Aspirin in the Treatment and Prevention of Cardiovascular Disease

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 3, 2004-11 ,pp. : 1-13

Karger

Access to resources Recommend Favorite

Serum Cholesterol Concentration and Atherosclerotic Cardiovascular Disease in the Aged

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 22, Iss. 2, 1974-02 ,pp. : 56-61

John Wiley & Sons Inc

Access to resources Recommend Favorite

Aspirin for prevention of cancer and cardiovascular disease

By Rose Peter W   Watson Eila K   Jenkins Lucy SC  

British Journal of General Practice, Vol. 61, Iss. 587, 2011-06 ,pp. : 412-415

Royal College of General Practitioners

Access to resources Recommend Favorite

Cardiovascular disease prevention and markers of hyperlipoproteinemia

By Gaddi Antonio V   Malvi Cristina  

Future Lipidology, Vol. 2, Iss. 3, 2007-06 ,pp. : 255-258

Future Medicine

Access to resources Recommend Favorite